Zai Lab (ZLAB) Stock: Buy, Sell, or Hold?
ZLAB - Zai Lab Limited American Depositary Shares
$24.14
-0.03 (-0.12%)
▼
5d:
-10.59%
30d:
-5.3%
90d:
+36.85%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When ZLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ZLAB is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ZLAB is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ZLAB is currently trading at $24.14, which is considered fair relative to its 30-day fair value range of $22.20 to $27.23.
Technical Outlook: Technically, ZLAB is in a uptrend. The price is currently testing key support at $23.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ZLAB scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.14 (+37.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZLAB is in a uptrend. The price is currently testing key support at $23.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ZLAB scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.14 (+37.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$22.20 -
$27.23
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (21/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.3% below Wall St target ($33.14)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$22.20 -
$27.23
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$23.64
Resistance Level
$27.50
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.44
Wall Street Target
$33.14
(+37.3%)
Revenue Growth (YoY)
-3.3%
Profit Margin
-41.9%
Share & Embed Analysis
Last updated: September 11, 2026 7:48 PM ET
Data refreshes hourly during market hours. Next update: 8:48 PM
Data refreshes hourly during market hours. Next update: 8:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZLAB showing a specific setup today?
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Rafael Amado
SELL
2739 shares
2026-04-06
Yajing Chen
SELL
853 shares
2026-04-06
Ying Du
SELL
2653 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$315 | 47 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
